Levobupivacaína Altan

Levobupivacaine, the active ingredient in Levobupivacaína Altan, is a local anesthetic presented as a sterile solution for epidural, infiltration, intrathecal and peripheral nerve block use. It provides surgical anesthesia, post‑operative analgesia and obstetric analgesia in adult patients. It is indicated for use in a variety of surgical procedures, including orthopedic, general and obstetric surgeries, delivering prolonged analgesia with a favorable safety profile.

GNH USA supplies Levobupivacaína Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Levobupivacaine is a long‑acting local anesthetic used to achieve analgesia and anesthesia in various clinical settings.

- Surgical anesthesia: provides dense anesthesia for a range of surgical procedures. - Post‑operative analgesia: extends pain relief after surgery, reducing opioid requirement. - Obstetric analgesia: enables labor pain control while maintaining maternal and fetal safety.

Levobupivacaine may cause adverse reactions at the site of administration or systemically.

Common Side Effects: - Injection site pain: mild discomfort at the injection area. - Transient hypotension: temporary drop in blood pressure. - Bradycardia: slowed heart rate. - Nausea: mild nausea. - Metallic taste: occasional taste disturbance.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Seizures: central nervous system excitation leading to convulsions. - Methemoglobinemia: abnormal hemoglobin causing cyanosis. - Allergic reaction: rash, itching, or anaphylaxis.

Precautions should be observed to minimize the risk of toxicity and ensure safe use of Levobupivacaine. Dose individualization: adjust based on patient age, weight, and comorbidities. Cardiovascular monitoring: observe heart rate and blood pressure during administration. Avoid intravascular injection: aspirate before injection to prevent systemic toxicity. Use with caution in hepatic impairment: reduced metabolism may increase exposure. Pregnancy and lactation: limited data, use only if benefit outweighs risk. Store at room temperature: keep in original container, protect from light and moisture.

Levobupivacaine can interact with other medicines, altering its safety profile or effectiveness. Major Interactions (Avoid): - Other local anesthetics: additive toxicity risk. - Class I antiarrhythmics (e.g., quinidine): increased cardiotoxicity. - CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma levels.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance bradycardia. - Calcium channel blockers: may affect cardiac conduction. - Opioids: synergistic CNS depression.